MAGE-H1, part of the MAGE (Melanoma Antigen) family of proteins, represents a group of antigens that were initially identified. The MAGE proteins are characterized by a shared MAGE homology domain and are further categorized into different subfamilies based on their sequence similarities and expression patterns. While the MAGE family has been extensively studied in the context of their potential as tumor antigens, the exact biological functions of individual MAGE proteins, including MAGE-H1, are not fully understood. However, some MAGE proteins have been suggested to play roles in cell cycle regulation, apoptosis, and other cellular processes.
Inhibitors targeting MAGE-H1 would be molecules developed to modulate the function, expression, or stability of the MAGE-H1 protein. Considering the potential roles of MAGE proteins in various cellular processes, inhibiting MAGE-H1 could influence the dynamics of cell cycle regulation, apoptosis, or other pathways in which MAGE-H1 may be involved. Potential inhibitors might encompass small molecules that bind directly to MAGE-H1, affecting its conformation or preventing its interaction with other proteins. Peptides or molecules that mimic the interaction sites of MAGE-H1 could also serve as competitive inhibitors, disrupting its interactions within cellular pathways. Additionally, molecular tools such as RNA interference or antisense oligonucleotides might be employed to reduce MAGE-H1 expression at the genetic level. Investigating the effects of MAGE-H1 inhibition can offer insights into its specific roles within cells. Such understanding would enhance our knowledge of the MAGE family's contributions to cellular functions and dynamics, and the broader implications of modulating these protein interactions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-azacytidine can demethylate DNA, potentially altering gene transcription patterns and affecting the expression of genes like MAGE-H1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
TSA is an HDAC inhibitor. By altering histone acetylation, it can influence gene transcription, potentially impacting MAGE-H1 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat, also known as SAHA, is another HDAC inhibitor that can modify chromatin and potentially down-regulate MAGE-H1. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
Gefitinib is an EGFR inhibitor. Since EGFR signaling can be linked to tumorigenic processes, it might influence MAGE-H1 expression. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib targets BCR-ABL, c-KIT, and PDGFR, potentially affecting tumor-related pathways and the expression of genes like MAGE-H1. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen is an estrogen receptor modulator, and by affecting hormone-related pathways, might influence MAGE-H1 expression. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $41.00 $143.00 | 27 | |
Bicalutamide is an androgen receptor antagonist and might influence MAGE-H1 expression in hormone-responsive. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, can affect cellular growth and proliferation pathways, potentially influencing MAGE-H1 expression. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
Lenalidomide affects multiple pathways, including angiogenesis and immune modulation, potentially impacting MAGE-H1 levels. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide has immunomodulatory and antiangiogenic properties, which might influence genes like MAGE-H1. | ||||||